As of February 2026, the pharmaceutical administration landscape is undergoing a structural realignment toward non-invasive, patient-centric modalities, with the Transdermal Drug Delivery Systems Market serving as a primary engine for therapeutic adherence. The transition from traditional passive patches to active transport mechanisms—such as iontophoresis, sonophoresis, and...